Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162,190,120
-
Number of holders
-
394
-
Total 13F shares, excl. options
-
39,714,489
-
Shares change
-
-2,702,073
-
Total reported value, excl. options
-
$8,429,599,286
-
Value change
-
-$519,994,166
-
Put/Call ratio
-
103%
-
Number of buys
-
222
-
Number of sells
-
-177
-
Price
-
$212.31
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q2 2021
521 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q2 2021.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 394 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39,714,489 shares
of 162,190,120 outstanding shares and own 24.5% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6,670,660 shares), FMR LLC (4,885,203 shares), BlackRock Inc. (4,555,420 shares), RA CAPITAL MANAGEMENT, L.P. (2,559,918 shares), STATE STREET CORP (1,693,390 shares), FRANKLIN RESOURCES INC (1,099,662 shares), GEODE CAPITAL MANAGEMENT, LLC (882,728 shares), CITADEL ADVISORS LLC (683,468 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (670,645 shares), and AMERIPRISE FINANCIAL INC (638,088 shares).
This table shows the top 394 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.